跳至主要内容
临床试验/ISRCTN74746075
ISRCTN74746075已完成未知

Accuracy of a rapid intrapartum test for maternal group B streptococcal colonisation and its potential to reduce antibiotic usage in mothers with risk factors

Queen Mary, University of London (QMUL)0 个研究点目标入组 1,625 人开始时间: 2015年4月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,625

研究概览

简要总结

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35027057/ (added 18/01/2022) 2022 Funder report results in https://pubmed.ncbi.nlm.nih.gov/35195519/ (added 24/02/2022)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • Current inclusion criteria as of 26/04/2018:
  • Presence of one or more of the following risk factors will define inclusion of the mother and baby into the study:
  • 1. Previous baby with early or late onset neonatal GBS disease as reported by the mother and documented in the maternal notes.
  • 2. GBS bacteriuria during current pregnancy, as documented in the maternal notes, irrelevant of whether the GBS bacteriuria was treated at the time of diagnosis with antibiotics.
  • 3. GBS colonisation of the vagina and/or rectum (determined from a vaginal/rectal swab) in current pregnancy, as documented in the maternal notes.
  • 4. Preterm labour (<37 weeks’ gestation), with intact membranes or rupture of membranes of any duration, whether suspected, diagnosed or established.
  • 5. Maternal pyrexia (>38°C) observed at any point in labour, including clinically suspected/confirmed chorioamnionitis
  • Previous inclusion criteria:
  • Presence of one or more of the following risk factors will define inclusion of the mother and baby into the study:
  • 1. The mother has delivered a previous baby who developed neonatal GBS disease (early or later onset), as reported by the mother and documented in the maternal notes
  • 2. GBS bacteriuria during the current pregnancy, as documented in the maternal notes, irrelevant of whether the GBS bacteriuria was treated at the time of diagnosis with antibiotics
  • 3. GBS colonisation of the vagina and/or the rectum (determined from a recto/vaginal swab) in current pregnancy, as documented in the maternal notes
  • 4. Maternal pyrexia (>38°C) observed at any point in labour, or clinically suspected/confirmed chorioamnionitis
  • 5. Preterm labour with prelabour rupture of membranes of any duration
  • 6. Preterm labour if there is suspected or confirmed intrapartum rupture of membranes lasting more than 18 hours

排除标准

  • Current participant exclusion criteria as of 01/05/2018:
  • Those who do not have any of the risk factors associated with an increased risk of being colonised by GBS
  • Previous participant exclusion criteria as of 26/04/2018:
  • 1. Aged under 16 years
  • 2. Women in labour at a gestation age of <24 weeks
  • 3. Women who, on arrival at the maternity unit, are already in second stage labour or who are likely to deliver their baby imminently
  • 4. Women whose baby is known to have died in utero or who has a congenital anomaly incompatible with survival at birth
  • 5. Women having an elective Caesarean delivery, which will be performed even if presenting in labour
  • Previous participant exclusion criteria:
  • Those who do not present with any of the risk factors associated with an increased risk of being colonised by GBS

研究者

发起方
Queen Mary, University of London (QMUL)

相似试验